MICAFUNGIN
Generic: MICAFUNGIN
Zydus Pharmaceuticals USA Inc.Manufacturer
INTRAVENOUSRoute
MICAFUNGIN SODIUMActive Substance
2022-10-24Original Approval
MICAFUNGIN is FDA application ANDA215241, sponsored by ZYDUS PHARMS. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
DRUG INEFFECTIVE
1,058 reports
2
OFF LABEL USE
665 reports
3
PYREXIA
470 reports
4
FEBRILE NEUTROPENIA
424 reports
5
PRODUCT USE IN UNAPPROVED INDICATION
311 reports
6
PNEUMONIA
310 reports
7
SEPSIS
302 reports
8
DIARRHOEA
267 reports
9
MULTIPLE ORGAN DYSFUNCTION SYNDROME
263 reports
10
NEUTROPENIA
251 reports